Isis Shines, PTC Therapeutics Soars – Zacks.com

Isis Shines, PTC Therapeutics Soars
Zacks.com
Fovista is the most advanced anti-PDGF agent in development for the treatment of wet age-related macular degeneration. The deal looks good for Ophthotech, which stands to gain a lot financially. Plus, Novartis has lots of experience in the eye care

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment